Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intravenous midazolam on duration of spinal anesthesia
IRCT2014090716415N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midazolam in intrathecal anesthesia, sponsored by Isfahan University of Medical Sciences. Primary endpoint: Duration of spinal anesthesia. Started May 2014; status: completed.
02
Drugs
midazolam
03
Conditions
intrathecal anesthesia
Beyond the preview
Go deeper on IRCT2014090716415N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014090716415N5.